Benchmark Upgrades Neogenomics (NEO) to Buy
Tweet
Share
E-mail
Get Alerts NEO Hot Sheet
Price: $17.58 -0.45%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 51
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 51
Join SI Premium – FREE
Benchmark analyst Bruce Jackson upgraded Neogenomics (NASDAQ: NEO) from Hold to Buy.
For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.
Shares of Neogenomics closed at $9.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Copart nears $2B all-cash deal to acquire ACV Auctions - Bloomberg
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- DigitalOcean secures $725M equipment financing facility
Create E-mail Alert Related Categories
UpgradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
